创新药杀疯了。在经历长达4年坍塌式的萎靡不振之后,一场由创新药企带动的新风暴正袭来。港股创新药板块持续拉升,尤其是在重磅BD预期之下,个股动辄20cm。多只港股创新药ETF的年内涨幅突破50%,多家创新药企实现翻倍甚至数倍增长。引爆点何在?是中国创新药企研发实力的跨越式提升,是BD出海浪潮的愈演愈烈,更是AACR、ASCO等国际顶级学术会议上,中国药企密集亮剑带来的价值重估。都说十年一个周期,创新...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.